Volume 28, Number 6—June 2022
Economic Burden of Reported Lyme Disease in High-Incidence Areas, United States, 2014–2016
||Patient perspective, cost per participant,* 2016 US dollars
*Cost per participant according to the patient perspective represents the sum of patient medical costs, nonmedical costs, cost of productivity losses, and other related costs as reported by each participant on all surveys. †Estimates for the overall population use the sample-weighted data except the range.